PepJunkie Home of the Peptonauts
More

Peptide Atlas · Peptide

Thymalin

Thymalin is a polypeptide complex extracted from the thymus; the dipeptides KE (Lys-Glu) and EW (Glu-Trp) are described as its active substances.

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Summary

Thymalin is a polypeptide complex extracted from the thymus; the dipeptides KE (Lys-Glu) and EW (Glu-Trp) are described as its active substances. · pmid:37686182

Mechanism

In cultured human hematopoietic stem cells, thymalin lowered CD44 and CD117 expression two- to threefold and raised CD28 6.8-fold, which the authors read as stimulated differentiation toward mature T lymphocytes. · pmid:33237528

Identity

No public registry record is shown for this page: PubChem gave no record that proves it is this substance.


Where the evidence actually sits

Preclinical only100%

Proportion of the 2 claims about Thymalin standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.


Living evidence history

Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. (2020) · preclinicalThe Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. (2023) · preclinical20202023

2 resolved citations, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.


Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Thymalin yet.


Dose evidence, rung by rung

No established safe human dose. Nothing on file establishes one. That is a statement about the evidence PepJunkie holds, not a promise about the molecule.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier

    nothing resolved on this rung

  3. Observational evidence · resolved human data at the emerging tier: thin, or contested

    nothing resolved on this rung

  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work
    • Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. · pmid 33237528 · 2020
    • The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. · pmid 37686182 · 2023

2 resolved citations, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.